Ipca Laboratories has informed that the Company has incorporated a wholly owned subsidiary (WOS) by the name ‘Ipca Pharmaceuticals GmbH’ in the Federal Republic of Germany, with an initial paidup capital of Euro € 25,000, to hold product registrations, participate in the institutional and other business and undertake distribution of generic formulations in the said country.
The above information is a part of company’s filings submitted to BSE.